JPH0346465B2 - - Google Patents

Info

Publication number
JPH0346465B2
JPH0346465B2 JP27829589A JP27829589A JPH0346465B2 JP H0346465 B2 JPH0346465 B2 JP H0346465B2 JP 27829589 A JP27829589 A JP 27829589A JP 27829589 A JP27829589 A JP 27829589A JP H0346465 B2 JPH0346465 B2 JP H0346465B2
Authority
JP
Japan
Prior art keywords
methyl
formula
mixture
tetrahydrofuran
reduced pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP27829589A
Other languages
Japanese (ja)
Other versions
JPH02167259A (en
Inventor
Buratsudoshoo Jon
Watoson Kurizero Jon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of JPH02167259A publication Critical patent/JPH02167259A/en
Publication of JPH0346465B2 publication Critical patent/JPH0346465B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/12Radicals substituted by nitrogen atoms not forming part of a nitro radical

Description

【発明の詳細な説明】 本発明はアジリジン誘導体およびその製造法に
関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to aziridine derivatives and methods for producing the same.

式() で示されるフラン誘導体は、ラニチジンとして知
られ、英国特許第1565966号明細書に有効なしか
も選択的なH2−拮抗剤として示されている。
formula() The furan derivative represented by is known as ranitidine and has been shown in British Patent No. 1,565,966 as an effective and selective H2 -antagonist.

本発明は、R1R2Nがエチレンイミノ基である 式() で示されるアジリジン誘導体、すなわち、式
() で示されるN−メチル−α−(ニトロメチレン)−
1−アジリジン−メタンアミン、およびその製造
法を提供するものである。
The present invention provides the formula () in which R 1 R 2 N is an ethyleneimino group. An aziridine derivative represented by the formula () N-methyl-α-(nitromethylene)-
The present invention provides 1-aziridine-methanamine and a method for producing the same.

本発明における化合物は、式()で示される
フラン誘導体の製造において重要なものである。
従つて、以下の説明は、この観点からなされてい
る。
The compound in the present invention is important in the production of the furan derivative represented by formula ().
Accordingly, the following description is made from this perspective.

式()で示されるフラン誘導体は、 式() で示されるチオールと、式() 〔ただし式中、R1は−CH2CH2L基(ただし、
Lは離脱する基)であり、R2は水素原子である
か、或いはR1およびR2はそれに結合している窒
素原子とともにエチレンイミノ基を形成する〕で
示されるアルキル化剤とを反応させることにより
製造することができる。
The furan derivative represented by the formula () is given by the formula () The thiol represented by and the formula () [However, in the formula, R 1 is a -CH 2 CH 2 L group (however,
L is a leaving group) and R 2 is a hydrogen atom, or R 1 and R 2 together with the nitrogen atom bonded thereto form an ethyleneimino group]. It can be manufactured by

好適な離脱基Lの例は、ハロゲン原子であり、
塩素が好ましい。
An example of a suitable leaving group L is a halogen atom,
Chlorine is preferred.

この方法は、化合物ラニチジンの新規かつ有用
な製法である。
This method is a new and useful method for producing the compound ranitidine.

R1が−CH2CH2L基でありR2が水素原子である
とき、この方法は適当な溶媒例えば水、含水テト
ラヒドロフラン、ジメチルホルムアミド、アルカ
ノール(例えばメタノール)又はケトン性溶媒例
えばアセトン(任意に水を添加)中で実施され
る。反応は、好ましくは、塩基例えば無機塩基
(例えばアルカリ金属炭酸塩又は水酸化物例えば
炭酸カリウム又は水酸化カリウム或いは水酸化ナ
トリウム)、アルコキシド(例えば、ナトリウム
メトキシド)或いは第三級アミン(例えば、トリ
エチルアミン)の存在下、適当な温度例えば10〜
80℃の範囲内で行われる。反応は、好ましくは、
不活性雰囲気中例えば窒素中で行われる。この方
法の変型として、式()で示されるチオール
は、相転移触媒(例えば、第四級アンモニウム塩
例えばベンジルトリエチルアンモニウムクロライ
ド)および塩基(例えば水酸化ナトリウム)の存
在下、例えばクロロホルムおよび水を用いる二相
系中で、アルキル化剤()と反応させられる。
When R 1 is a -CH 2 CH 2 L group and R 2 is a hydrogen atom, the process can be carried out using a suitable solvent such as water, aqueous tetrahydrofuran, dimethylformamide, an alkanol (e.g. methanol) or a ketonic solvent such as acetone (optionally). (addition of water). The reaction is preferably carried out using a base such as an inorganic base (such as an alkali metal carbonate or hydroxide such as potassium carbonate or potassium hydroxide or sodium hydroxide), an alkoxide (such as sodium methoxide) or a tertiary amine (such as triethylamine). ) in the presence of a suitable temperature e.g.
It is carried out within the range of 80℃. The reaction is preferably
It is carried out in an inert atmosphere, for example nitrogen. In a variant of this method, thiols of formula In a two-phase system, it is reacted with an alkylating agent ().

アルキル化反応を実施するのに特に有用な条件
は、アルカリ金属水酸化物(例えば、水酸化カリ
ウム)と水との存在下か、又は溶媒として含水テ
トラヒドロフランを用いる炭酸カリウムの存在
下、式()(ただし式中、R1は−CH2CH2C1基
であり、R2が水素原子である)で示されるアル
キル化剤により式()で示されるチオールを処
理することを含む。有利には、反応は窒素の雰囲
気下室温で実施される。
Particularly useful conditions for carrying out the alkylation reaction are in the presence of an alkali metal hydroxide (e.g., potassium hydroxide) and water, or in the presence of potassium carbonate using aqueous tetrahydrofuran as the solvent. (wherein R 1 is a -CH 2 CH 2 C1 group and R 2 is a hydrogen atom) includes treating a thiol represented by the formula () with an alkylating agent represented by the following. Advantageously, the reaction is carried out at room temperature under an atmosphere of nitrogen.

R1およびR2がそれらに結合している窒素原子
と共にエチレンイミノ基を形成するとき、反応は
溶媒の存在下又は非存在下実施される。適当な溶
媒は、水、アルカノール(例えば、メタノール)
又はジメチルホルムアミドを含む。反応は、好ま
しくは、加熱例えば100℃により、不活性雰囲気
例えば窒素中で実施される。
When R 1 and R 2 together with the nitrogen atom attached to them form an ethyleneimino group, the reaction is carried out in the presence or absence of a solvent. Suitable solvents include water, alkanols (e.g. methanol)
or dimethylformamide. The reaction is preferably carried out under an inert atmosphere, such as nitrogen, with heating, for example 100°C.

チオール()は、直接用いられるか又は酸付
加塩例えばシユウ酸塩からその場で生成される。
一方、反応が塩基の存在下で実施されるとき、チ
オール()は、反応の塩基性条件下、イソチオ
尿素()又はその塩例えばビスマレイン酸塩か
らその場で生成される。
Thiols () can be used directly or generated in situ from acid addition salts such as oxalates.
On the other hand, when the reaction is carried out in the presence of a base, the thiol () is generated in situ from the isothiourea () or a salt thereof such as bismaleate under the basic conditions of the reaction.

式()で示されるチオールは、濃縮された酸例
えば濃塩酸の存在下チオ尿素と式() で示される対応するアルコールとを反応させてイ
ソチオ尿素()を生成させ、それは次に好まし
くは抗酸化剤例えばナトリウムジチオナイト又は
メタ重亜硫酸ナトリウムの存在下、塩基例えば炭
酸ナトリウム又は5N水酸化ナトリウムによる処
理により、式()で示されるチオールに転換さ
れる。単離されると、このように形成された遊離
の塩基は、好ましくは溶媒例えばテトラヒドロフ
ラン中で、適当な酸特にシユウ酸による処理によ
り、安定な酸付加塩に転換される。
A thiol of formula () can be prepared by combining thiourea with formula () in the presence of a concentrated acid e.g. concentrated hydrochloric acid. to form an isothiourea (), which is then reacted with a base such as sodium carbonate or 5N sodium hydroxide, preferably in the presence of an antioxidant such as sodium dithionite or sodium metabisulfite. The treatment converts it into a thiol represented by formula (). Once isolated, the free base so formed is converted into a stable acid addition salt by treatment with a suitable acid, especially oxalic acid, preferably in a solvent such as tetrahydrofuran.

もしイソチオ尿素()を単離することが望ま
しいならば、これはまた好ましくは溶媒例えばテ
トラヒドロフラン中、適当な酸による処理によ
り、安定な塩例えばビスマレイン酸塩の形で好ま
しくは単離される。
If it is desired to isolate the isothiourea (), it is also preferably isolated in the form of a stable salt, such as the bismaleate, by treatment with a suitable acid, preferably in a solvent such as tetrahydrofuran.

R1がCH2CH2L基(ただし、Lがハロゲン例え
ば塩素である)であり、R2が水素原子である式
()で示される化合物は、好ましくは塩例えば
塩酸塩の形のハロアルキルアミン例えばクロロエ
チルアミンと、式() (ただし、式中、L′は離脱する基例えばメチル
チオ基である)で示される化合物とを反応させる
ことにより製造される。反応は、適当な溶媒例え
ば水中で、塩基例えばトリエチルアミンの存在
下、そして好ましくは高温度例えば約100℃で実
施される。
Compounds of formula () in which R 1 is a CH 2 CH 2 L group (wherein L is a halogen, e.g. chlorine) and R 2 is a hydrogen atom, are preferably haloalkylamines in the form of salts, e.g. hydrochlorides. For example, chloroethylamine and the formula () (In the formula, L' is a leaving group such as a methylthio group.) The reaction is carried out in a suitable solvent, such as water, in the presence of a base, such as triethylamine, and preferably at an elevated temperature, such as about 100°C.

R1R2Nがエチレンイミノ基である式()で
示される化合物は、式() (ただし式中、L″は離脱する基例えばC1-4
ルコキシ基又はC1-4アルキルチオ基好ましくはメ
チルチオ基である)で示されるニトロエテンアミ
ンとエチレンイミンとの反応により製造される。
反応は、適当な非プロトン性溶媒例えばアセトニ
トリル中で実施される。
A compound represented by the formula () in which R 1 R 2 N is an ethyleneimino group is a compound represented by the formula () (wherein L'' is a leaving group such as a C 1-4 alkoxy group or a C 1-4 alkylthio group, preferably a methylthio group) and is produced by the reaction of nitroethenamine with ethyleneimine.
The reaction is carried out in a suitable aprotic solvent such as acetonitrile.

式()で示されるチオールの酸付加塩、
R1R2Nがエチレンイミノ基である式()で示
される化合物即ち式() で示される化合物そして式()で示されるイソ
チオ尿素およびその酸付加塩は、すべて新規な化
合物である。
Acid addition salt of thiol represented by formula (),
Compounds represented by formula () in which R 1 R 2 N is an ethyleneimino group, i.e., formula () The compound represented by formula (), the isothiourea represented by formula (), and its acid addition salt are all new compounds.

式()で示されたチオールおよび式()で
示されたイソチオ尿素は特に安定でないが、それ
らは酸付加塩の形に転換することにより安定化さ
れることが知られている。この安定な酸付加塩の
例は、塩酸塩、硫酸塩、アルキルスルホン酸塩、
アリールスルホン酸塩、酢酸塩、フマール酸塩、
マレイン酸塩および安息香酸塩を含む。式()
で示されるチオールの好ましい酸付加塩は、シユ
ウ酸塩であり、そしてイソチオ尿素()の好ま
しい酸付加塩は、ビスマレイン酸塩である。
Although thiols of formula () and isothioureas of formula () are not particularly stable, it is known that they can be stabilized by converting them into acid addition salt form. Examples of this stable acid addition salt are hydrochloride, sulfate, alkyl sulfonate,
Aryl sulfonates, acetates, fumarates,
Contains maleate and benzoate. formula()
A preferred acid addition salt of the thiol represented by is the oxalate salt, and a preferred acid addition salt of the isothiourea () is the bismaleate salt.

本発明は、次の例により説明される。 The invention is illustrated by the following example.

なお、下記の製造4が本発明によるN−メチル
−α−(ニトロメチレン)−1−アジリジン−メタ
ンアミンの製造例であり、また下記の参考例3が
本発明によるこのN−メチル−α−(ニトロメチ
レン)−1−アジリジン−メタンアミンからのラ
ニチジンの製造例である。
Note that Production 4 below is an example of producing N-methyl-α-(nitromethylene)-1-aziridine-methanamine according to the present invention, and Reference Example 3 below is a production example of N-methyl-α-(nitromethylene)-1-aziridine-methanamine according to the present invention. This is an example of the production of ranitidine from (nitromethylene)-1-aziridine-methanamine.

製造例 1 1−〔〔〔5−〔(ジメチルアミノ)メチル〕−2−
フラニル〕メチル〕チオ〕メタンイミドアミド、
マレイン酸塩(1:2) 5−〔(ジメチルアミノ)メチル〕−2−フラン
メタノール(3.1g)を濃塩酸(5ml)中のチオ
尿素(1.53g)の溶液に徐々に添加した。18時間
室温に放置した後、溶液を30分間98〜100゜に加熱
した。溶液を冷却し、テトラヒドロフラン(100
ml)および過剰の無水炭酸ナトリウムを添加し、
30分後に混合物を過した。無水テトラヒドロフ
ラン(40ml)中のマレイン酸(4.65g)の溶液を
液に加え、分離した固体を過し、テトラヒド
ロフランおよびエーテルで洗うと、標題の化合物
(8.1g)融点144−145゜が得られた。
Production example 1 1-[[[5-[(dimethylamino)methyl]-2-
Furanyl]methyl]thio]methanimidamide,
Maleate salt (1:2) 5-[(dimethylamino)methyl]-2-furanmethanol (3.1 g) was added slowly to a solution of thiourea (1.53 g) in concentrated hydrochloric acid (5 ml). After standing at room temperature for 18 hours, the solution was heated to 98-100° for 30 minutes. Cool the solution and add tetrahydrofuran (100
ml) and excess anhydrous sodium carbonate;
After 30 minutes the mixture was filtered. A solution of maleic acid (4.65g) in anhydrous tetrahydrofuran (40ml) was added to the liquid and the solid that separated was filtered and washed with tetrahydrofuran and ether to give the title compound (8.1g) mp 144-145°. .

製造例 2 5−〔(ジメチルアミノ)メチル〕−2−フラン
メタンチオール、シユウ酸塩(1:1) 5−〔(ジメチルアミノ)メチル〕−2−フラン
メタノール(7.76g)を濃塩酸(12.5ml)中のチ
オ尿素(3.81g)の溶液に徐々に加えた。18時間
後、溶液を98−100゜で30分間加熱し、蒸発させて
減量させた。水(50ml)中の水酸化ナトリウムの
溶液およびナトリウムジチオナイト(10g)を加
え、1時間後溶液をエーテル(6×50ml)で抽出
した。ホウ酸(35g)を水性部分に加え、顕濁物
をエーテル(4×50ml)で抽出した。合わせたエ
ーテル性抽出物にナトリウムジオナイト(2g)
および過剰の無水炭酸ナトリウムを加えた。3時
間後、混合物の無水テトラヒドロフラン(60ml)
中のシユウ酸(6.3g)の溶液に過した。分離
した固体を過し、テトラヒドロフランで洗滌
し、乾燥して標題の化合物(5.84g)融点116.5
−118゜を得た。
Production Example 2 5-[(dimethylamino)methyl]-2-furanmethanethiol, oxalate (1:1) 5-[(dimethylamino)methyl]-2-furanmethanol (7.76 g) was dissolved in concentrated hydrochloric acid (12.5 g). ml) of thiourea (3.81 g). After 18 hours, the solution was heated at 98-100° for 30 minutes to evaporate and reduce the weight. A solution of sodium hydroxide in water (50ml) and sodium dithionite (10g) were added and after 1 hour the solution was extracted with ether (6 x 50ml). Boric acid (35g) was added to the aqueous portion and the suspension was extracted with ether (4 x 50ml). Sodium dionite (2 g) to the combined ethereal extracts
and excess anhydrous sodium carbonate were added. After 3 hours, dry tetrahydrofuran (60 ml) of the mixture
The mixture was filtered through a solution of oxalic acid (6.3 g). The solid that separated was filtered, washed with tetrahydrofuran, and dried to give the title compound (5.84 g), mp 116.5.
−118° was obtained.

製造 3 N−(2−クロロエチル)−N′−メチル−2−
ニトロ−1,1−エテンジアミン 98−100゜の水(4ml)中のN−メチル−(1−
メチルチオ)−2−ニトロエテンアミン(5.93g)
および2−クロロエタンアミン塩酸塩(18.56g)
の溶液に、トリエチルアミン(24ml)を加えた。
混合物を10分間98−100゜で撹拌し、50分間真空
(12−20mm)にした。水(8ml)を加え、混合物
を20分間98−100゜で減圧下で加熱した。アセトン
(200ml)および過剰の無水硫酸マグネシウムを残
渣に加え、懸濁物を45分間還流した。固体を去
し、加熱アセトン(3×50ml)で洗滌した。合わ
せた液および洗滌液を冷却し、得られた結晶状
沈殿物を別した。液を100mlに濃縮し、分離
した固体を去し、液を蒸発して減量し、クロ
マトグラフ(シリカ/アセトン)にかけた。適切
な溶出液を減圧蒸発させ、残渣を酢酸エチル:エ
ーテル(1:4)に懸濁し、過すると、標題の
化合物(2.8g)融点113−115゜を得た。t.l.c.シリ
カ:2−ブタノン:Rf0.4。
Production 3 N-(2-chloroethyl)-N'-methyl-2-
Nitro-1,1-ethenediamine N-methyl-(1-
Methylthio)-2-nitroethenamine (5.93g)
and 2-chloroethanamine hydrochloride (18.56g)
Triethylamine (24 ml) was added to the solution.
The mixture was stirred for 10 minutes at 98-100° and applied vacuum (12-20 mm) for 50 minutes. Water (8ml) was added and the mixture was heated under reduced pressure at 98-100° for 20 minutes. Acetone (200ml) and excess anhydrous magnesium sulfate were added to the residue and the suspension was refluxed for 45 minutes. The solids were removed and washed with hot acetone (3 x 50ml). The combined liquid and washing liquid were cooled and the resulting crystalline precipitate was separated. The liquid was concentrated to 100 ml, the separated solid was removed, the liquid was evaporated to a reduced volume and chromatographed (silica/acetone). The appropriate eluate was evaporated in vacuo and the residue suspended in ethyl acetate:ether (1:4) and filtered to give the title compound (2.8g) mp 113-115°. tlc silica: 2-butanone: Rf0.4.

製造 4(実施例) N−メチル−α−(ニトロメチレン)−1−アジ
リジン−メタンアミン アセトニトリル(5ml)中のエチレンイミン
(0.47g)およびN−メチル−(1−メチルチオ)
−2−ニトロエテンアミン(1.48g)の溶液を2
日間室温で撹拌した。懸濁物を室温で減圧蒸発さ
せ、残渣を熱酢酸エチル(100ml)で抽出した。
抽出物の減圧蒸発により残渣を得、それを酢酸エ
チル(50ml)中に懸濁し、過した。液を蒸発
して約5mlとし、クロマトグラフ(シリカ/酢酸
エチル)にかけた。適切な溶出液〔TLC(シリ
カ/酢酸エチル)Rf0.28〕を減圧蒸発して標題化
合物(0.33g)融点118−119゜を得た。
Preparation 4 (Example) N-Methyl-α-(nitromethylene)-1-aziridine-methanamine Ethyleneimine (0.47 g) and N-methyl-(1-methylthio) in acetonitrile (5 ml)
-2-Nitroethenamine (1.48g) solution
The mixture was stirred at room temperature for several days. The suspension was evaporated under reduced pressure at room temperature and the residue was extracted with hot ethyl acetate (100ml).
Evaporation of the extract under reduced pressure gave a residue, which was suspended in ethyl acetate (50ml) and filtered. The liquid was evaporated to approximately 5 ml and chromatographed (silica/ethyl acetate). The appropriate eluent [TLC (silica/ethyl acetate) Rf 0.28] was evaporated under reduced pressure to give the title compound (0.33g) mp 118-119°.

製造 5 5−〔(ジメチルアミノ)メチル〕−2−フラン
メタンチオールシユウ酸塩(1:1) 水(140ml)およびエーテル(160ml)中の炭酸
カリウム(83.5g)、メタ重亜硫酸ナトリウム
(22.9g)および1−〔〔〔5−〔(ジメチルアミノ)
メチル〕−2−フラニル〕メチル〕チオ〕メタン
イミドアミドマレイン酸塩(1:2)(26.73g)
の混合物を、24時間室温で窒素雰囲気中で撹拌し
た。無水炭酸ナトリウム(10g)を加え、さらに
2時間撹拌した後エーテル部分を分離し、水(60
ml)中のメタ重亜硫酸ナトリウム(5g)および
炭酸カリウム(8g)の溶液で洗滌した。エーテ
ル抽出物を1時間乾燥(Na2SO4)し、テトラヒ
ドロフラン(100ml)中のシユウ酸(7.6g)の溶
液中に過した。分離した固体(13.33g)をテ
トラヒドロフランから結晶させると標題化合物
(12.20g)、融点116.5−119゜を得た。
Preparation 5 5-[(dimethylamino)methyl]-2-furanmethanethiol oxalate (1:1) Potassium carbonate (83.5 g), sodium metabisulfite (22.9 g) in water (140 ml) and ether (160 ml) ) and 1-[[[5-[(dimethylamino)
Methyl]-2-furanyl]methyl]thio]methanimidamide maleate (1:2) (26.73g)
The mixture was stirred for 24 hours at room temperature under nitrogen atmosphere. After adding anhydrous sodium carbonate (10 g) and stirring for an additional 2 hours, the ether portion was separated and water (60 g) was added.
ml) of sodium metabisulfite (5 g) and potassium carbonate (8 g). The ether extract was dried (Na 2 SO 4 ) for 1 hour and filtered into a solution of oxalic acid (7.6 g) in tetrahydrofuran (100 ml). The separated solid (13.33g) was crystallized from tetrahydrofuran to give the title compound (12.20g), mp 116.5-119°.

参考例 1 N−〔2−〔〔5−〔(ジメチルアミノ)メチル〕−
2−フラニルメチル〕チオ〕エチル〕−N′−メチ
ル−2−ニトロ−1,1−エテンジアミン N−(2−クロロエチル)−N′−メチル−2−
ニトロ−1,1−エテンジアミン(0.9g)、5−
〔(ジメチルアミノ)メチル〕−2−フランメタン
チオールシユウ酸塩(1:1)(1.3g)および炭
酸カリウム(2.7g)の水(10ml)およびテトラ
ヒドロフラン(10ml)中の混合物を5日間室温で
窒素中で撹拌した。懸濁物を減圧蒸発させ、残渣
を水(40ml)と混合し、懸濁物をエーテル(2×
30ml)で抽出した。水性部分を減圧蒸発させ、残
渣をエタノール(2×10ml)と共に蒸発させた。
テトラヒドロフラン(20ml)、MgSO4および脱色
炭を加え、1時間後混合物を過した。液を蒸
発させて油(1g)を得、それをクロマトグラフ
(シリカ/メタノール:0.88アンモニア79:1)
にかけた。適切な溶出液を蒸発させ、油状の残渣
(0.66g)を熱酢酸イソプロピルにより抽出した。
分離した固体を過すると、標題化合物(0.4
g)、融点65−68゜を得、それは英国特許第
1565966号の実施例15の方法により製造したサン
プルと混合しても低下しなかつた。
Reference example 1 N-[2-[[5-[(dimethylamino)methyl]-
2-Furanylmethyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine N-(2-chloroethyl)-N'-methyl-2-
Nitro-1,1-ethenediamine (0.9g), 5-
A mixture of [(dimethylamino)methyl]-2-furanmethanethiol oxalate (1:1) (1.3 g) and potassium carbonate (2.7 g) in water (10 ml) and tetrahydrofuran (10 ml) was stirred at room temperature for 5 days. Stir under nitrogen. The suspension was evaporated under reduced pressure, the residue was mixed with water (40 ml) and the suspension was dissolved in ether (2x
30ml). The aqueous portion was evaporated under reduced pressure and the residue co-evaporated with ethanol (2x10ml).
Tetrahydrofuran (20ml), MgSO 4 and decolorizing charcoal were added and after 1 hour the mixture was filtered. The liquid was evaporated to obtain an oil (1 g), which was chromatographed (silica/methanol: 0.88 ammonia 79:1).
I put it on. The appropriate eluate was evaporated and the oily residue (0.66g) extracted with hot isopropyl acetate.
Filtration of the separated solid yielded the title compound (0.4
g), with a melting point of 65-68°, which is claimed in British patent no.
Even when mixed with the sample prepared by the method of Example 15 of No. 1565966, there was no decrease.

参考例 2 N−〔2−〔〔5−〔(ジメチルアミノ)メチル〕−
2−フラニルメチル〕チオ〕エチル〕−N′−メチ
ル−2−ニトロ−1,1−エテンジアミン 水(10ml)およびテトラヒドロフラン(10ml)
中の1−〔〔〔5−〔(ジメチルアミノ)メチル〕−2
−フラニル〕メチル〕チオ〕メタンイミドアミド
マレイン酸塩(1:2)(2.23g)、N−(2−ク
ロロエチル)−N′−メチル−2−ニトロ−1,1
−エテンジアミン(0.9g)および炭酸カリウム
(3.46g)の混合物を5日間室温で窒素中で撹拌
した。懸濁物を減圧蒸発させ、残渣を水(5ml)
中に懸濁させ、エーテル(2×40ml)で抽出し
た。水性部分を減圧蒸発させ、硫酸マグネシウム
およびテトラヒドロフラン(100ml)を加えた。
18時間後、混合物を過し、液を蒸発させて半
固体を得、それをクロマトグラフ(シリカ/メタ
ノール)にかけた。適切な溶出液を減圧蒸発させ
て標題化合物(0.3g)を得、それは前述の実施
例1に従つて作つた生成物のn.m.r.と同じn.m.r
を有した。
Reference example 2 N-[2-[[5-[(dimethylamino)methyl]-
2-Furanylmethyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine Water (10ml) and tetrahydrofuran (10ml)
1-[[[5-[(dimethylamino)methyl]-2
-furanyl]methyl]thio]methanimidamide maleate (1:2) (2.23 g), N-(2-chloroethyl)-N'-methyl-2-nitro-1,1
- A mixture of ethenediamine (0.9 g) and potassium carbonate (3.46 g) was stirred for 5 days at room temperature under nitrogen. The suspension was evaporated under reduced pressure and the residue was dissolved in water (5 ml).
and extracted with ether (2 x 40ml). The aqueous portion was evaporated under reduced pressure and magnesium sulphate and tetrahydrofuran (100ml) were added.
After 18 hours, the mixture was filtered and the liquid was evaporated to give a semi-solid which was chromatographed (silica/methanol). Evaporation of the appropriate eluate under reduced pressure afforded the title compound (0.3 g), which had the same nmr as that of the product made according to Example 1 above.
It had

参考例 3 N−〔2−〔〔5−〔(ジメチルアミノ)メチル〕−
2−フラニル−メチル〕チオ〕エチル〕−N′−メ
チル−2−ニトロ−1,1−エテンジアミン 水(0.4ml)中の5−〔(ジメチルアミノ)メチ
ル〕−2−フランメタンチオールシユウ酸塩
(1:1)(0.156g)、ナトリウムジオナイト
(0.05g)および無水炭酸ナトリウム(0.15g)
の混合物に、エーテル(15ml)および過剰の炭酸
ナトリウムを加えた。混合物を過し、液を減
圧蒸発させた。残渣に、N−メチル−α−(ニト
ロメチレン)−1−アジリジンメタンアミン
(0.072g)およびメタノール(2ml)を加え、溶
液を蒸発乾固させた。残渣を1.25時間98−100゜で
加熱し、生成物をクロマトグラフ(シリカ/メタ
ノール:0.88アンモニア、79:1)にかけた。適
切な溶出液を減圧蒸発させると標題化合物
(0.113g)を得、それは上述の実施例の生成物の
n.m.r.と同じn.m.r.を有した。
Reference example 3 N-[2-[[5-[(dimethylamino)methyl]-
2-furanyl-methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine 5-[(dimethylamino)methyl]-2-furanmethanethiol oxalic acid in water (0.4 ml) Salt (1:1) (0.156g), sodium dionite (0.05g) and anhydrous sodium carbonate (0.15g)
To the mixture was added ether (15ml) and excess sodium carbonate. The mixture was filtered and the liquid was evaporated under reduced pressure. To the residue N-methyl-α-(nitromethylene)-1-aziridinemethanamine (0.072g) and methanol (2ml) were added and the solution was evaporated to dryness. The residue was heated at 98-100° for 1.25 hours and the product was chromatographed (silica/methanol:0.88 ammonia, 79:1). Evaporation of the appropriate eluate under reduced pressure afforded the title compound (0.113g), which was similar to the product of the example above.
It had the same nmr as nmr.

参考例 4 N−〔2−〔〔5−〔(ジメチルアミノ)メチル〕−
2−フラニルメチル〕チオ〕エチル〕−N′−メチ
ル−2−ニトロ−1,1−エテンジアミン 窒素の雰囲気下45゜の水(20ml)中の5−〔(ジ
メチルアミノ)メチル〕−2−フランメタン−チ
オールシユウ酸塩(1:1)(1.31g)およびN
−(2−クロロエチル)−N′−メチル−2−ニト
ロ−1,1−エテンジアミン(1.08g)の撹拌し
た混合物に、水(3ml)中の水酸化カリウム
(1.04g)の溶液を加えた。溶液を2.5時間45゜で撹
拌し、次に15時間室温で撹拌した。溶液を次に減
圧蒸発させ、残渣を水に溶解し、空気流を15分間
混合物中に通した。混合物をエーテル(2×15
ml)で抽出し、水性部分を減圧蒸発させた。残渣
に、テトラヒドロフラン(70ml)、過剰の無水炭
酸ナトリウムおよび脱色炭を加えた。1時間後、
混合物を過し、液を減圧蒸発させ、油状残渣
を4−メチル−ペンタン−2−オン(8mlに溶解
した。分離した固体を過し、4−メチルペンタ
ン−2−オンで洗滌すると標題化合物(0.72g)、
融点63−66゜を得、それは英国特許第1565966号の
実施例15の方法に従つて作つたサンプルと混合し
ても低下しなかつた。
Reference example 4 N-[2-[[5-[(dimethylamino)methyl]-
2-Furanylmethyl[thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine 5-[(dimethylamino)methyl]-2-furan in water (20 ml) at 45° under nitrogen atmosphere. Methane-thiol oxalate (1:1) (1.31 g) and N
To a stirred mixture of -(2-chloroethyl)-N'-methyl-2-nitro-1,1-ethenediamine (1.08g) was added a solution of potassium hydroxide (1.04g) in water (3ml). . The solution was stirred for 2.5 hours at 45° and then for 15 hours at room temperature. The solution was then evaporated under reduced pressure, the residue was dissolved in water and a stream of air was passed through the mixture for 15 minutes. Pour the mixture into ether (2 x 15
ml) and the aqueous portion was evaporated under reduced pressure. To the residue was added tetrahydrofuran (70ml), excess anhydrous sodium carbonate and decolorizing charcoal. 1 hour later
The mixture was filtered, the liquid was evaporated under reduced pressure and the oily residue was dissolved in 8 ml of 4-methyl-pentan-2-one. The solid that separated was filtered and washed with 4-methylpentan-2-one to give the title compound ( 0.72g),
A melting point of 63-66° was obtained, which did not decrease when mixed with a sample made according to the method of Example 15 of GB 1565966.

参考例 5 N−〔2−〔〔5−〔(ジメチルアミノ)メチル〕−
2−フラニルメチル〕チオ〕エチル〕−N′−メチ
ル−2−ニトロ−1,1−エテンジアミン 窒素の雰囲気下の45゜の水(20ml)中の1−〔5
−〔(ジメチルアミノ)メチル〕−2−フラニルメ
チル〕チオ〕メタンイミドジアミドマレイン酸塩
(1:2)(2.23g)およびN−(2−クロロエチ
ル)−N′−メチル−2−ニトロ−1,1−エテン
ジアミン(1.08g)の撹拌した溶液に、水(3
ml)中の水酸化カリウム(1.68g)の溶液を加え
た。室温で40時間後、溶液をエーテル(2×50
ml)で抽出し、水性相を減圧蒸発させた。テトラ
ヒドロフラン(70ml)、脱色炭および過剰の無水
炭酸ナトリウムを残渣に加え、混合物を30分間還
流した。3時間後、混合物を過し、液を減圧
蒸発させて半固体を得、それをメタノールおよび
アセトンの混合物に溶解し、クロマトグラフ(シ
リカ:メタノール:アセトン1:1)にかけた。
適切な溶出液を減圧蒸発させて油(0.37g)とし
て標題化合物を得、その一部を4−メチルペンタ
ン−2−オンで結晶化(融点68−70゜)し、それ
は英国特許第1565966号の実施例15の方法に従つ
て作つたサンプルと混合しても低下しなかつた。
Reference example 5 N-[2-[[5-[(dimethylamino)methyl]-
2-Furanylmethyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine 1-[5 in water (20 ml) at 45° under an atmosphere of nitrogen
-[(dimethylamino)methyl]-2-furanylmethyl]thio]methanimidodiamide maleate (1:2) (2.23 g) and N-(2-chloroethyl)-N'-methyl-2-nitro-1, To a stirred solution of 1-ethenediamine (1.08 g) was added water (3
A solution of potassium hydroxide (1.68g) in ml) was added. After 40 hours at room temperature, the solution was dissolved in ether (2 x 50
ml) and the aqueous phase was evaporated under reduced pressure. Tetrahydrofuran (70ml), decolorizing charcoal and excess anhydrous sodium carbonate were added to the residue and the mixture was refluxed for 30 minutes. After 3 hours, the mixture was filtered and the liquid was evaporated under reduced pressure to obtain a semi-solid, which was dissolved in a mixture of methanol and acetone and chromatographed (silica:methanol:acetone 1:1).
Evaporation of the appropriate eluate under reduced pressure gave the title compound as an oil (0.37 g), a portion of which was crystallized from 4-methylpentan-2-one (melting point 68-70°), which is described in British Patent No. 1565966. It did not decrease even when mixed with a sample prepared according to the method of Example 15.

Claims (1)

【特許請求の範囲】 1 N−メチル−α−(ニトロメチレン)−1−ア
ジリジン−メタンアミン。 2 エチレンイミンと式() 〔式中、L″は、C1-4アルコキシ基またはC1-4
ルキルチオ基である〕で示されるニトロエテンア
ミンとを反応させることからなる、N−メチル−
α−(ニトロメチレン)−1−アジリジン−メタン
アミンの製造法。 3 L″がメチルチオ基である、特許請求の範囲
第2項に記載の方法。
[Claims] 1 N-methyl-α-(nitromethylene)-1-aziridine-methanamine. 2 Ethyleneimine and the formula () N - methyl-
A method for producing α-(nitromethylene)-1-aziridine-methanamine. 3. The method according to claim 2, wherein L'' is a methylthio group.
JP27829589A 1980-01-08 1989-10-25 Aziridine derivative and production thereof Granted JPH02167259A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB00581 1980-01-08
GB8000581 1980-01-08
GB8000580 1980-01-08
GB00580 1980-01-08
GB39336 1980-12-08
GB8039336 1980-12-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP83381A Division JPS56103171A (en) 1980-01-08 1981-01-08 Manufacture of furan derivative

Publications (2)

Publication Number Publication Date
JPH02167259A JPH02167259A (en) 1990-06-27
JPH0346465B2 true JPH0346465B2 (en) 1991-07-16

Family

ID=27260837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27829589A Granted JPH02167259A (en) 1980-01-08 1989-10-25 Aziridine derivative and production thereof

Country Status (14)

Country Link
JP (1) JPH02167259A (en)
AR (1) AR225940A1 (en)
AT (1) AT376966B (en)
CH (1) CH650257A5 (en)
DE (1) DE3100364A1 (en)
DK (1) DK157865C (en)
ES (1) ES8200673A1 (en)
FI (1) FI80450C (en)
FR (1) FR2473044A1 (en)
HU (1) HU182272B (en)
NL (1) NL8100068A (en)
PT (1) PT72320B (en)
SE (2) SE449747B (en)
YU (1) YU42372B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3213509A1 (en) * 1982-04-10 1983-10-20 Basf Ag, 6700 Ludwigshafen N-SUBSTITUTED IMIDAZOLE DERIVATIVES, THEIR PRODUCTION, THE MEDICINES CONTAINING THEM AND THEIR USE
YU42819B (en) * 1982-11-22 1988-12-31 Lek Tovarna Farmacevtskih Process for preparing n-/2-///5-(dimethyl-amino)-methyl-2-furanyl/methyl/thio/ethyl-n'-methyl-2-nitro-1,1-ethene diamine
NL8303965A (en) * 1982-12-08 1984-07-02 Degussa NEW FOOD DIAMINE AND GUANIDINE DERIVATIVES; METHOD FOR PREPARING THEREOF MEDICINES CONTAINING THEM; METHOD FOR PREPARING SUCH MEDICINES; APPLICATION OF THE COMPOUNDS FOR THE PREPARATION OF MEDICINAL PRODUCTS AND IN MEDICINE.
DE3343884A1 (en) * 1982-12-08 1984-06-14 Degussa Ag, 6000 Frankfurt Novel ethenediamine and guanidine derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL56265A (en) 1977-12-28 1982-08-31 Om Lab Sa Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor
NO784350L (en) * 1977-12-30 1979-07-03 Crc Ricerca Chim PROCEDURE FOR ALKYLATION OF 4 (5) -MERCAPTOMETHYL-IMIDAZOLES WITH AZIRIDINE DERIVATIVES
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
NO811501L (en) * 1980-05-13 1981-11-16 Crc Ricerca Chim PROCEDURE FOR THE PREPARATION OF ETHENDIAMINE DERIVATIVES, AND INTERMEDIATES FOR THESE

Also Published As

Publication number Publication date
DE3100364A1 (en) 1981-11-19
DK7181A (en) 1981-07-09
FI810039L (en) 1981-07-09
AT376966B (en) 1985-01-25
SE8502780L (en) 1985-06-05
DK157865C (en) 1990-07-30
SE8100074L (en) 1981-07-09
SE460604B (en) 1989-10-30
CH650257A5 (en) 1985-07-15
FR2473044A1 (en) 1981-07-10
FI80450C (en) 1990-06-11
FI80450B (en) 1990-02-28
ATA3781A (en) 1984-06-15
SE8502780D0 (en) 1985-06-05
FR2473044B1 (en) 1984-04-13
PT72320A (en) 1981-02-01
DK157865B (en) 1990-02-26
AR225940A1 (en) 1982-05-14
ES498389A0 (en) 1981-11-16
PT72320B (en) 1982-07-23
ES8200673A1 (en) 1981-11-16
YU42372B (en) 1988-08-31
JPH02167259A (en) 1990-06-27
YU2781A (en) 1983-06-30
DE3100364C2 (en) 1989-12-28
SE449747B (en) 1987-05-18
HU182272B (en) 1983-12-28
NL8100068A (en) 1981-08-03

Similar Documents

Publication Publication Date Title
CA2003283A1 (en) Imidazoles for the treatment of atherosclerosis
JPS6139943B2 (en)
JPH0224827B2 (en)
JPH0346465B2 (en)
US4968808A (en) Process for the preparation of nitroethene derivatives
SU428602A3 (en) METHOD OF OBTAINING BASIC-SUBSTITUTE DERIVATIVES 1
US3131218A (en) N-amino guanidine derivatives
SU1227111A3 (en) Method of producing guanidine derivatives or their tautomeric compounds or their salts
US4413135A (en) Intermediates in the preparation of ranitidine
SU420176A3 (en)
KR850001934B1 (en) Process for the preparation of a furan derivative
CA1100146A (en) Derivatives of r,s-[2-(2-hydroxyethylamino)-1- phenyl]-ethylamine, and a process of obtaining them
US4460506A (en) Nitrovinyl aziridine derivative
CZ296040B6 (en) 2-Thiothiazolidin-5-one compound, process for its preparation and method of its conversion to 2-imidazolin-5-one compound
US5030738A (en) Synthesis of antiulcer compounds
FI84059B (en) Production of N-/2-//5(dimethylamino)methyl/-2- furanylmethyl/thio/ethyl/-N1-methyl-2-nitro-1,1-etedin amine
JPH0256354B2 (en)
EP0299034A1 (en) Process for the preparation of compounds with antiulcer action.
US4468518A (en) Imidazole guanidine compounds and method of making same
JPS62155268A (en) Synthesis of nizatidine
DK164501B (en) PROCEDURE FOR MANUFACTURING NIZATIDINE AND INTERMEDIATE PRODUCTS FOR USING THE PROCEDURE
KR810001914B1 (en) Process for preparing amino alkyl furan derivatives
JPH0730063B2 (en) Method for producing ranitidine or acid addition salt thereof
CS197312B2 (en) Method of producing 3,4-dimethoxy-6-/4-/2-furoyl/-1-piperazinyl-thiocarbamido/benzonitrile
HU220341B (en) Process for producing substituted pyrimidin derivatives